FA info icon.svgAngle down icon.svgMedical equipment data
Health topic Child mortality
Health classification Treatment
FA info icon.svgAngle down icon.svgProject data
Location Bangladesh
Status Clinical trial
Made No
Replicated No
OKH Manifest Download

Problem being addressed[edit | edit source]

Pneumonia is a major cause of death for infants and children in resource-limited settings. Since oxygen therapy is expensive and requires medical professionals, antibiotics are the often the only treatment.

Detailed description of the solution[edit | edit source]

Inspire converts room air into pressurized gas to expand patients' lung instead of using oxygen tanks like traditional bubble CPAP methods. Doctors can direct oxygen into the Inspire device if oxygen supplements are necessary. Since pure oxygen in excess doses can result in blindness and asthma, this device is also safer for less-trained professionals to use.

Designed by[edit | edit source]

  • Designed by: A team at Stanford University
  • Manufacturer location: Stanford University

When and where it was tested/implemented[edit | edit source]


Funding Source[edit | edit source]

National Institutes of Health grant

References[edit | edit source]

Other internally generated reports[edit | edit source]

Pavkov, Pamela. (2011). INSPIRE: Evaluating a Transition to Product Development. Retrieved November 29, 2013 from here.

Externally generated reports[edit | edit source]

Pavkov, Pamela. (July 5, 2011). OpenIDEO. Inspire: a low-cost breathing assistant for infants in rural settings. Retrieved November 29, 2013 from here.

FA info icon.svgAngle down icon.svgPage data
Part of Global Health Medical Device Compendium
SDG SDG03 Good health and well-being, SDG09 Industry innovation and infrastructure
Authors Kelly Wojcik
License CC-BY-SA-3.0
Language English (en)
Related 0 subpages, 1 pages link here
Impact 262 page views
Created November 30, 2013 by Kelly Wojcik
Modified September 28, 2022 by Irene Delgado
Cookies help us deliver our services. By using our services, you agree to our use of cookies.